Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 16,965,000 | 16,889,600 | 13,090,300 | 12,509,900 | 11,558,800 |
| Cost of Goods | 9,209,000 | 9,397,601 | 7,561,200 | 7,214,400 | 6,764,800 |
| Gross Profit | 7,756,000 | 7,491,999 | 5,529,100 | 5,295,500 | 4,794,000 |
| Operating Expenses | 5,420,000 | 4,989,600 | 3,919,700 | 3,813,800 | 3,544,000 |
| Operating Income | 2,336,000 | 2,503,000 | 1,609,600 | 1,482,100 | 1,250,800 |
| Other Income | -400,000 | -415,800 | -290,100 | -212,700 | -118,000 |
| Pre-tax Income | 1,936,000 | 2,087,200 | 1,319,500 | 1,269,400 | 1,132,800 |
| Income Tax | -44,000 | 191,700 | 40,400 | 11,000 | 109,400 |
| Net Income Continuous | 1,980,000 | 1,895,500 | 1,279,100 | 1,258,400 | 1,023,400 |
| Net Income Discontinuous | -5,000 | -1,100 | -5,800 | -80,500 | 306,500 |
| Net Income | $1,975,000 | $1,894,400 | $1,273,300 | $1,177,900 | $1,329,900 |
| EPS Basic Total Ops | 4.96 | 4.76 | 3.53 | 3.24 | 3.49 |
| EPS Basic Continuous Ops | 4.97 | 4.76 | 3.55 | 3.46 | 2.69 |
| EPS Basic Discontinuous Ops | -0.01 | 0.00 | -0.02 | -0.22 | 0.80 |
| EPS Diluted Total Ops | 4.92 | 4.71 | 3.48 | 3.21 | 3.46 |
| EPS Diluted Continuous Ops | 4.93 | 4.71 | 3.50 | 3.43 | 2.66 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.00 | -0.02 | -0.22 | 0.80 |
| EBITDA(a) | $4,024,000 | $4,187,799 | $2,609,500 | $2,465,802 | $2,110,400 |